Clinical Trial Update: Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two immunosuppressive regimens in de novo kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Rejection

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Graft Rejection, Kidney Failure | Phase 4 | Status: COMPLETED